The Effect of Whole Body Vibration After ACLR
Launched by CHINESE UNIVERSITY OF HONG KONG · Feb 17, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how an 8-week program of whole body vibration (WBV) training can help improve muscle strength and knee function in patients recovering from anterior cruciate ligament (ACL) reconstruction surgery. The goal is to see if this type of training makes it easier for people to perform movements like single-leg squats and hops, which are important for returning to physical activities after an ACL injury.
To participate in this study, you need to be between the ages of 18 and 50 and have been active in sports before your injury. You should also be scheduled for ACL reconstruction due to a sports injury and be able to walk with crutches about a month after your surgery. However, if you have certain other knee injuries or medical conditions, or if you've been pregnant, you may not be eligible. If you join the trial, you can expect to undergo the vibration training over 8 weeks and have your progress monitored to see how it helps your recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18-50;
- • 2. Physically active before injury with Tegner score more than 6 (recreational/professional sport level);
- • 3. Scheduled for ACLR because of sport injury;
- • 4. Be able to walk with a pair of elbow crutches independently at 1 month after ACLR.
- Exclusion Criteria:
- • 1. Concomitant posterior cruciate ligament or lateral collateral ligament injury in the same knee;
- • 2. Injury to the contralateral side;
- • 3. Medical problems that are contradictory to WBV;
- • 4. Prior experience of WBV to avoid any training or memory effect;
- • 5. Women with pregnancy.
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Xin He, PhD
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials